Literature DB >> 22899649

Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots.

Yudong Li1, Li Zhang, Robyn L Ball, Xinle Liang, Jianrong Li, Zhenguo Lin, Han Liang.   

Abstract

Somatic copy-number alterations (SCNAs) play a crucial role in the development of human cancer. However, it is not well understood what evolutionary mechanisms contribute to the global patterns of SCNAs in cancer genomes. Taking advantage of data recently available through The Cancer Genome Atlas, we performed a systematic analysis on genome-wide SCNA breakpoint data for eight cancer types. First, we observed a high degree of overall similarity among the SCNA breakpoint landscapes of different cancer types. Then, we compiled 19 genomic features and evaluated their effects on the observed SCNA patterns. We found that evolutionary indel and substitution rates between species (i.e. humans and chimpanzees) consistently show the strongest correlations with breakpoint frequency among all the surveyed features; whereas the effects of some features are quite cancer-type dependent. Focusing on SCNA breakpoint hotspots, we found that cancer-type-specific breakpoint hotspots and common hotspots show distinct patterns. Cancer-type-specific hotspots are enriched with known cancer genes but are poorly predicted from genomic features; whereas common hotspots show the opposite patterns. This contrast suggests that explaining high-frequency SCNAs in cancer may require different evolutionary models: positive selection driven by cancer genes, and non-adaptive evolution related to an intrinsically unstable genomic context. Our results not only present a systematic view of the effects of genetic factors on genome-wide SCNA patterns, but also provide deep insights into the evolutionary process of SCNAs in cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22899649      PMCID: PMC3607479          DOI: 10.1093/hmg/dds340

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  A fine-scale map of recombination rates and hotspots across the human genome.

Authors:  Simon Myers; Leonardo Bottolo; Colin Freeman; Gil McVean; Peter Donnelly
Journal:  Science       Date:  2005-10-14       Impact factor: 47.728

Review 2.  The evolution of animal chemosensory receptor gene repertoires: roles of chance and necessity.

Authors:  Masatoshi Nei; Yoshihito Niimura; Masafumi Nozawa
Journal:  Nat Rev Genet       Date:  2008-12       Impact factor: 53.242

Review 3.  Genetic instability and darwinian selection in tumours.

Authors:  D P Cahill; K W Kinzler; B Vogelstein; C Lengauer
Journal:  Trends Cell Biol       Date:  1999-12       Impact factor: 20.808

Review 4.  Gene amplification in cancer.

Authors:  Donna G Albertson
Journal:  Trends Genet       Date:  2006-06-19       Impact factor: 11.639

5.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

6.  Genomic drift and copy number variation of sensory receptor genes in humans.

Authors:  Masafumi Nozawa; Yoshihiro Kawahara; Masatoshi Nei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-05       Impact factor: 11.205

Review 7.  Chromosome fragile sites.

Authors:  Sandra G Durkin; Thomas W Glover
Journal:  Annu Rev Genet       Date:  2007       Impact factor: 16.830

8.  The UCSC Genome Browser database: extensions and updates 2011.

Authors:  Timothy R Dreszer; Donna Karolchik; Ann S Zweig; Angie S Hinrichs; Brian J Raney; Robert M Kuhn; Laurence R Meyer; Mathew Wong; Cricket A Sloan; Kate R Rosenbloom; Greg Roe; Brooke Rhead; Andy Pohl; Venkat S Malladi; Chin H Li; Katrina Learned; Vanessa Kirkup; Fan Hsu; Rachel A Harte; Luvina Guruvadoo; Mary Goldman; Belinda M Giardine; Pauline A Fujita; Mark Diekhans; Melissa S Cline; Hiram Clawson; Galt P Barber; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2011-11-15       Impact factor: 16.971

9.  Prevalence of quadruplexes in the human genome.

Authors:  Julian L Huppert; Shankar Balasubramanian
Journal:  Nucleic Acids Res       Date:  2005-05-24       Impact factor: 16.971

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

View more
  6 in total

1.  Detection of candidate tumor driver genes using a fully integrated Bayesian approach.

Authors:  Jichen Yang; Xinlei Wang; Minsoo Kim; Yang Xie; Guanghua Xiao
Journal:  Stat Med       Date:  2013-12-18       Impact factor: 2.373

2.  Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis.

Authors:  Anne Bruun Krøigård; Martin Jakob Larsen; Anne-Vibeke Lænkholm; Ann S Knoop; Jeanette D Jensen; Martin Bak; Jan Mollenhauer; Torben A Kruse; Mads Thomassen
Journal:  Oncotarget       Date:  2015-03-20

3.  Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues.

Authors:  Stefanie Marczok; Birgit Bortz; Chong Wang; Heike Pospisil
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 4.  [Next-generation sequencing for lung cancer].

Authors:  Kehua Wu; R Stephanie Huang; Larry House; William Chi Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-01

5.  Targeted next-generation sequencing at copy-number breakpoints for personalized analysis of rearranged ends in solid tumors.

Authors:  Hyun-Kyoung Kim; Won Cheol Park; Kwang Man Lee; Hai-Li Hwang; Seong-Yeol Park; Sungbin Sorn; Vishal Chandra; Kwang Gi Kim; Woong-Bae Yoon; Joon Seol Bae; Hyoung Doo Shin; Jong-Yeon Shin; Ju-Young Seoh; Jong-Il Kim; Kyeong-Man Hong
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

6.  Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?

Authors:  Gustavo Dos Santos Fernandes; Daniel da Motta Girardi; Luiza Dib Batista Bugiato Faria; João Paulo Giacomini Bernardes; Renata de Almeida Coudry
Journal:  J Immunother Cancer       Date:  2017-11-21       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.